These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Hass R, Bartels H, Topley N, Hadam M, Köhler L, Goppelt-Strübe M, Resch K. Eur J Cell Biol; 1989 Apr; 48(2):282-93. PubMed ID: 2744002 [Abstract] [Full Text] [Related]
6. Characterization of human TUR leukemia cells: continued cell cycle progression in the presence of phorbol ester is associated with resistance to apoptosis. Hass R, Meinhardt G, Hadam M, Bartels H. Eur J Cell Biol; 1994 Dec; 65(2):408-16. PubMed ID: 7720732 [Abstract] [Full Text] [Related]
7. Activation of protein kinase C relays distinct signaling pathways in the same cell type: differentiation and caspase-mediated apoptosis. Meinhardt G, Roth J, Hass R. Cell Death Differ; 2000 Sep; 7(9):795-803. PubMed ID: 11042674 [Abstract] [Full Text] [Related]
8. Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation. de Vente J, Kiley S, Garris T, Bryant W, Hooker J, Posekany K, Parker P, Cook P, Fletcher D, Ways DK. Cell Growth Differ; 1995 Apr; 6(4):371-82. PubMed ID: 7794805 [Abstract] [Full Text] [Related]
14. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Arita Y, Buffolino P, Coppock DL. Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525 [Abstract] [Full Text] [Related]
15. Flow cytometric analysis of the phenotypic changes in tumour cell lines following TPA induction. Zanyk MJ, Banerjee D, McFarlane DL. Cytometry; 1988 Jul 01; 9(4):374-9. PubMed ID: 3402283 [Abstract] [Full Text] [Related]
16. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells. Ito Y, Mishra NC, Yoshida K, Kharbanda S, Saxena S, Kufe D. Cell Death Differ; 2001 Aug 01; 8(8):794-800. PubMed ID: 11526432 [Abstract] [Full Text] [Related]
17. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S. Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135 [Abstract] [Full Text] [Related]
18. Resistance to phorbol ester-induced differentiation in human myeloid leukemia cells: a hypothetic role for the mRNA stabilization process. Champelovier P, Pautre V, Elatifi M, Dupré I, Rostaing B, Michoud A, Berger F, Seigneurin D. Leuk Res; 2006 Nov 15; 30(11):1407-16. PubMed ID: 16757024 [Abstract] [Full Text] [Related]
19. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine. Niitsu N, Ishii Y, Matsuda A, Honma Y. Cancer Res; 2001 Jan 01; 61(1):178-85. PubMed ID: 11196157 [Abstract] [Full Text] [Related]
20. Lipoprotein modulation of the intracellular localization of protein kinase C and alteration of phorbol ester-stimulated differentiation in the human monoblastic U937 cell line. Ways DK, Dodd RC, Gwynne JT, Earp HS. Cancer Res; 1986 Dec 01; 46(12 Pt 1):6049-53. PubMed ID: 3465431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]